These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37316857)

  • 21. Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand.
    Geoghegan JL; Douglas J; Ren X; Storey M; Hadfield J; Silander OK; Freed NE; Jelley L; Jefferies S; Sherwood J; Paine S; Huang S; Sporle A; Baker MG; Murdoch DR; Drummond AJ; Welch D; Simpson CR; French N; Holmes EC; de Ligt J
    Emerg Infect Dis; 2021 May; 27(5):1317-1322. PubMed ID: 33900175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tracking SARS-CoV-2 introductions in Mozambique using pandemic-scale phylogenies: a retrospective observational study.
    Martínez-Martínez FJ; Massinga AJ; De Jesus Á; Ernesto RM; Cano-Jiménez P; Chiner-Oms Á; Gómez-Navarro I; Guillot-Fernández M; Guinovart C; Sitoe A; Vubil D; Bila R; Gujamo R; Enosse S; Jiménez-Serrano S; Torres-Puente M; Comas I; Mandomando I; López MG; Mayor A
    Lancet Glob Health; 2023 Jun; 11(6):e933-e941. PubMed ID: 37202028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Going hard and early: Aotearoa New Zealand's response to Covid-19.
    Cumming J
    Health Econ Policy Law; 2022 Jan; 17(1):107-119. PubMed ID: 33663626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wastewater monitoring of SARS-CoV-2 shows high correlation with COVID-19 case numbers and allowed early detection of the first confirmed B.1.1.529 infection in Switzerland: results of an observational surveillance study.
    Bagutti C; Alt Hug M; Heim P; Maurer Pekerman L; Ilg Hampe E; Hübner P; Fuchs S; Savic M; Stadler T; Topolsky I; Icer Baykal P; Dreifuss D; Beerenwinkel N; Tschudin Sutter S
    Swiss Med Wkly; 2022 Jun; 152():w30202. PubMed ID: 35822578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022.
    Nduwimana C; Nzoyikorera N; Ndihokubwayo A; Ihorimbere T; Nibogora C; Ndoreraho A; Hajayandi O; Bizimana JC; Diawara I; Niyonizigiye D; Nyandwi J
    BMC Genomics; 2023 Jun; 24(1):312. PubMed ID: 37301830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Provision of primary care in managed isolation and quarantine facilities during the COVID-19 pandemic: lessons learned from Christchurch, New Zealand.
    Al-Busaidi IS; Martin M
    N Z Med J; 2020 Jul; 133(1519):130-132. PubMed ID: 32777807
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased unemployment from the COVID-19 pandemic, what might be the adverse impacts on cardiovascular disease in Aotearoa/New Zealand and how might this be prevented?
    Nghiem N; Mizdrak A; Wilson N
    N Z Med J; 2020 Dec; 133(1526):89-98. PubMed ID: 33332343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand.
    Carlton LH; Chen T; Whitcombe AL; McGregor R; Scheurich G; Sheen CR; Dickson JM; Bullen C; Chiang A; Exeter DJ; Paynter J; Baker MG; Charlewood R; Moreland NJ
    Epidemiol Infect; 2021 Jul; 149():e173. PubMed ID: 34668464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic epidemiology and phylogenetics applied to the study of SARS-CoV-2 pandemic.
    Lai A; Bergna A; Della Ventura C; Zehender G
    New Microbiol; 2023 Feb; 46(1):1-8. PubMed ID: 36853811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mobilisation and analyses of publicly available SARS-CoV-2 data for pandemic responses.
    Rahman N; O'Cathail C; Zyoud A; Sokolov A; Oude Munnink B; Grüning B; Cummins C; Amid C; Nieuwenhuijse DF; Visontai D; Yuan DY; Gupta D; Prasad DK; Gulyás GM; Rinck G; McKinnon J; Rajan J; Knaggs J; Skiby JE; Stéger J; Szarvas J; Gueye K; Papp K; Hoek M; Kumar M; Ventouratou MA; Bouquieaux MC; Koliba M; Mansurova M; Haseeb M; Worp N; Harrison PW; Leinonen R; Thorne R; Selvakumar S; Hunt S; Venkataraman S; Jayathilaka S; Cezard T; Maier W; Waheed Z; Iqbal Z; Aarestrup FM; Csabai I; Koopmans M; Burdett T; Cochrane G
    Microb Genom; 2024 Feb; 10(2):. PubMed ID: 38358325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 Variants in Rhode Island.
    Kantor R; Novitsky V; Carpenter-Azevedo K; Howison M; Manne A; Darpolor JK; Bobenchik A; Tripathi A; Huard RC; King E
    R I Med J (2013); 2021 Sep; 104(7):16-20. PubMed ID: 34279520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 Pandemic Lockdown and Wellbeing: Experiences from Aotearoa New Zealand in 2020.
    Officer TN; Imlach F; McKinlay E; Kennedy J; Pledger M; Russell L; Churchward M; Cumming J; McBride-Henry K
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modelling Aotearoa New Zealand's COVID-19 protection framework and the transition away from the elimination strategy.
    Vattiato G; Lustig A; Maclaren O; Binny RN; Hendy SC; Harvey E; O'Neale D; Plank MJ
    R Soc Open Sci; 2023 Feb; 10(2):220766. PubMed ID: 36756071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic sequencing for epidemic and pandemic preparedness and response: EMRO's vision and strategic interventions.
    Al-Mandhari A; Barakat A; Abubakar A; Brennan R
    East Mediterr Health J; 2022 Dec; 28(12):851-852. PubMed ID: 36573563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determining Gaps in Publicly Shared SARS-CoV-2 Genomic Surveillance Data by Analysis of Global Submissions.
    Ohlsen EC; Hawksworth AW; Wong K; Guagliardo SAJ; Fuller JA; Sloan ML; O'Laughlin K
    Emerg Infect Dis; 2022 Dec; 28(13):S85-S92. PubMed ID: 36502409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A global aircraft-based wastewater genomic surveillance network for early warning of future pandemics.
    Li J; Hosegood I; Powell D; Tscharke B; Lawler J; Thomas KV; Mueller JF
    Lancet Glob Health; 2023 May; 11(5):e791-e795. PubMed ID: 37061316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of Public Health Genomics in Africa: Lessons from the COVID-19 pandemic, challenges, and recommendations.
    Moyo E; Moyo P; Mashe T; Dzobo M; Chitungo I; Dzinamarira T
    J Med Virol; 2023 Jan; 95(1):e28295. PubMed ID: 36366938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.